Clinical Trials Directory

Trials / Completed

CompletedNCT00278603

Stem Cell Injection for Peripheral Vascular Disease

Hematopoietic Stem Cell Injection for Peripheral Vascular Disease: Induction of Neoangiogenesis. A Phase I Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Severe peripheral vascular disease of the legs causes narrowing of the blood vessels in the legs, which keeps the blood from flowing adequately through these vessels. This study is designed to examine whether treating patients with their own previously collected blood stem cells will improve blood flow in the most severely affected leg. Blood stem cells are undeveloped cells that have the capacity to grow into mature blood cells, which normally circulate in the blood stream.

Conditions

Interventions

TypeNameDescription
BIOLOGICALStem Cell TransplantationAutologous Hematopoietic Stem Cell Injection

Timeline

Start date
2004-10-01
Primary completion
2008-10-01
Completion
2009-06-01
First posted
2006-01-18
Last updated
2012-04-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00278603. Inclusion in this directory is not an endorsement.

Stem Cell Injection for Peripheral Vascular Disease (NCT00278603) · Clinical Trials Directory